Valuation: Boston Scientific Corporation

Market Cap 67.64B 59.47B 55.36B 50.84B 95.46B 6,487B 96.72B 658B 257B 3,203B 254B 248B 11,071B P/E 2026 *
16.3x
P/E 2027 * 15.9x
Enterprise Value 74.2B 65.23B 60.72B 55.77B 105B 7,116B 106B 722B 282B 3,514B 279B 273B 12,145B EV / Sales 2026 *
3.44x
EV / Sales 2027 * 3.05x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day+2.85%
1 week+3.98%
Current month+6.63%
1 month+2.89%
3 months-24.09%
6 months-51.38%
Current year-52.27%
1 week 42.5
Extreme 42.5
46.32
1 month 42.2
Extreme 42.2
46.37
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
7/1/26 A Fiscal year

Chief Financial Officer

5,184 0.0004%
5/28/26 A Don

Chief Executive Officer

-386,755 0.0261%
5/20/26 A Buy

Director

3,580 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.85%+3.98%-57.12%-13.54% 67.64B
-1.54%+6.33%+16.98%-0.09% 208B
+2.61%-2.29%-4.37%-23.02% 138B
+5.73%+1.04%-28.04%+10.28% 126B
+0.50%-2.31%+3.80%+0.45% 47.81B
-0.37%+2.38%-26.20%-32.86% 45.03B
-0.49%+5.86%+14.74%+8.87% 38.94B
-0.93%+3.82%+22.53%+30.15% 36.45B
+4.00%+2.25%-26.20%-8.32% 29.29B
-2.38%+2.59%+73.35%-0.12% 28.67B
Average +1.01%+1.32%-1.05%-2.82% 76.6B
Weighted average by Cap. +1.26%+1.49%-3.58%-4.02%

Financials

2026 *2027 *
Net sales 21.57B 18.96B 17.65B 16.21B 30.43B 2,068B 30.83B 210B 81.93B 1,021B 80.95B 79.21B 3,530B 23.29B 20.48B 19.06B 17.5B 32.87B 2,234B 33.3B 227B 88.49B 1,103B 87.44B 85.55B 3,812B
Net income 3.94B 3.46B 3.22B 2.96B 5.55B 377B 5.63B 38.28B 14.95B 186B 14.77B 14.46B 644B 4.11B 3.62B 3.37B 3.09B 5.81B 394B 5.88B 40.01B 15.63B 195B 15.44B 15.11B 673B
Net Debt 6.56B 5.77B 5.37B 4.93B 9.25B 629B 9.38B 63.79B 24.91B 311B 24.62B 24.09B 1,073B 3.43B 3.01B 2.8B 2.57B 4.83B 329B 4.9B 33.32B 13.01B 162B 12.86B 12.58B 561B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
27/07/26 $45.51 +2.85% 20,044,682
24/07/26 $44.25 +1.54% 20,689,854
23/07/26 $43.58 +1.42% 16,535,740
22/07/26 $42.97 -0.51% 11,201,174
21/07/26 $43.19 -1.33% 25,009,837
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
45.51USD
Average target price
72.25USD
Spread / Average Target
+58.76%

Quarterly revenue - Rate of surprise